One of Time Magazine’s 10 best medical breakthroughs of 2007, Veridex’s GeneSearch™ Breast Lymph Node Assay can evaluate your lymph nodes more thoroughly for cancer cells than more commonly performed test procedures used during surgery. Given that more than 40,000 women in the U.S. die annually from breast cancer, the GeneSearch™ BLN Assay is the first intra-operative & gene-based test approved for use in the U.S. to detect the spread of breast cancer into the lymph nodes, and in this segment, our host discusses this test and what patients should know after they have been diagnosed with breast cancer when with Dr. Peter Blumencranz – one of the first doctors to use the test clinically after it became available on the market.
